In line with the in vitro test results, the xenograft model verified that silence of ABHD5 in RAW cells suppressed CT-26 tumour growth in an SRM-dependent manner (Fig. 3i and Supplementary Fig. 3k). The gene discussed is ABHD5; the disease is neoplasm.